- COMING SOON -

Our Questions, Your Answers

Here’s your chance to exchange strategies, ideas and inspiration with like-minded people committed
to facing their rosacea head-on. Each month, our experts will pose a question about how you’re
handling your condition—and we’re counting on you to share the details!

Brought to you
by Galderma

makers of Oracea^® and MetroGel^® 1%

Enter the first 3 digits
of your zip code

© 2010 Galderma Laboratories, L.P. United States, All Rights Reserved.
All trademarks are the property of their respective owners. This site intended for U.S. audiences only.
Information in this website is not intended as medical advice. Talk to your doctor about medical concerns.

Important Safety Information:

Oracea^® is indicated for the treatment of only inflammatory lesions (papules and pustules) of rosacea in adult patients. You may experience intestinal upsets, sore throat or sinus infections/sinusitis when taking Oracea^®. Do not take Oracea^® if you are allergic to tetracyclines, and it may cause harm to a developing fetus; so do not take Oracea^® if you are pregnant or breastfeeding. When taking Oracea^®, stay out of direct or artificial sunlight, and make sure you tell your doctor if you have stomach or GI problems, kidney disease, have a yeast or fungal infection, take blood thinners, take oral contraceptives, or take medicine to treat acne, psoriasis or seizures. Oracea^® does not treat bacterial infections. Use Oracea^® only as prescribed by your doctor. For more information about Oracea^®, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Important Safety Information:

MetroGel^® 1% is indicated for the topical treatment of the inflammatory lesions of rosacea. The following adverse experiences have been reported with the topical use of metronidazole: burning, skin irritation, dryness, transient redness, metallic taste, tingling or numbness of extremities and nausea. MetroGel^® 1% gel is contraindicated in individuals with a history of hypersensitivity to metronidazole or any other ingredients in this formulation. For more information about MetroGel^® 1%, see Full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Friend's Name:
Friend's Email
Message: